Coffin C M, Humphrey P A, Dehner L P
Department of Pathology, University of Utah School of Medicine, Salt Lake City, USA.
Semin Diagn Pathol. 1998 May;15(2):85-101.
Inflammatory myofibroblastic tumor (IMT) or inflammatory pseudotumor was initially recognized in the lung, and somewhat later, a similar-appearing pathological process was reported in the liver. Presently, this tumor has been described in virtually all major organs and extrapulmonary sites with a few exceptions. It was thought initially that the IMT was nonneoplastic and represented an aberrant inflammatory response despite its gross and microscopic features of a spindle cell neoplasm. The inflammatory hypothesis about the pathogenesis has been more readily accommodated in the lung than in the extrapulmonary sites of involvement. Some cases, however, were accompanied by the constitutional symptoms and signs of an inflammatory process, which resolved in most cases after surgical resection. There were some pathological aspects of the IMT that seemingly contradicted its purely inflammatory nature, including its potential for local recurrence; development of multifocal, noncontiguous tumors; infiltrative local growth; vascular invasion; and malignant transformation. These pathological features seemed to support the hypothesis that the IMT is a neoplastic process, which has been augmented by reports that these tumors have clonal characteristics. Other studies have suggested that IMTs of the liver and spleen are associated with the Epstein-Barr virus. From the diagnostic perspective, there are several potential difficulties that the pathologist may encounter in the examination of one of these tumors. Just as it was true 60 years ago, the potential for a pathological diagnosis of one or another type of spindle cell sarcoma has not diminished with time. Because these tumors have a predilection for children, embryonal rhabdomyosarcoma is another diagnostic temptation when an IMT presents in the bladder or other hollow viscus. The IMT should probably be regarded as a soft tissue-mesenchymal tumor with an indeterminant or low malignant potential, which is a somewhat indefinite but realistic prognostic category.
炎性肌纤维母细胞瘤(IMT)或炎性假瘤最初在肺部被认识到,此后不久,肝脏中也报道了类似的病理过程。目前,除少数例外,几乎在所有主要器官和肺外部位均有该肿瘤的描述。最初认为IMT是非肿瘤性的,尽管其大体和显微镜下表现为梭形细胞瘤,但代表一种异常的炎症反应。关于发病机制的炎症假说在肺部比在受累的肺外部位更容易被接受。然而,一些病例伴有炎症过程的全身症状和体征,大多数病例在手术切除后症状缓解。IMT的一些病理特征似乎与它纯粹的炎症性质相矛盾,包括其局部复发的可能性、多灶性非连续性肿瘤的发生、浸润性局部生长、血管侵犯以及恶性转化。这些病理特征似乎支持IMT是一种肿瘤性过程的假说,有报道称这些肿瘤具有克隆特征,这进一步支持了该假说。其他研究表明,肝脏和脾脏的IMT与EB病毒有关。从诊断角度来看,病理学家在检查这些肿瘤之一时可能会遇到几个潜在困难。正如60年前一样,诊断为某种类型梭形细胞肉瘤的可能性并未随着时间的推移而减少。由于这些肿瘤好发于儿童,当IMT出现在膀胱或其他中空脏器时,胚胎性横纹肌肉瘤是另一种容易误诊的疾病。IMT可能应被视为一种具有不确定或低恶性潜能的软组织间叶肿瘤,这是一个有些不明确但现实的预后类别。